The future of
Regenerative Medicine
Prometheus Regeneration is developing BioReJen®, a 3D-printed, graphene-enhanced biodegradable scaffold platform for bone regeneration, and in time regenerative joint implants.
A progressive regenerative strategy
One scaffold platform, staged across three orthopaedic applications of increasing complexity.
Bone Void Filler (BVF)
First commercial objective
A biodegradable, graphene-enhanced scaffold that supports bone regeneration, then degrades as new tissue forms.
Learn more →Revision Adjuncts
In development
Patient-specific regenerative cones, sleeves, augments and wedges for complex bone loss in revision arthroplasty.
Learn more →Next-Generation Implants
In development
Load-bearing regenerative implants that integrate with host tissue and are ultimately replaced by living bone.
Learn more →Starting in a growing orthopaedic market
The bone graft substitutes market is where BioReJen® is intended to launch first. It is the entry point for a single scaffold platform that then extends to more complex orthopaedic applications.
2024
2030
(CAGR)
Source: Grand View Research, Bone Grafts & Substitutes Market, 2024–2030.
Get in touch
On request, we share our investor presentation and the materials relevant to your enquiry with qualified parties.